PMA device
Superion Indirect Decompression System
Boston Scientific Neuromodulation · Prosthesis, Spinous Process Spacer/Plate (NQO, Class III) · First FDA decision Mar 24, 2017, newest Aug 22, 2024Degenerative disc disease and spinal stenosis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
13
PMA pathway
Device trials
3
Naming "Superion Indirect Decompression"
MAUDE reports
0
Brand "Superion Indirect Decompression", since 2015
PubMed studies
3
Mentioning "Superion Indirect Decompression"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Superion Indirect Decompression System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 13 decisions filed under this name.
FDA's records could not be loaded.
Older decisions: P140004-S012, P140004-S011, P140004-S010, P140004-S009, P140004-S008, P140004-S006, P140004-S005
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Superion Indirect Decompression", any status and sponsor, newest update first.
- A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)Active, not recruiting
Boston Scientific CorporationPublic (BSX)
NCT04192591 · 166 participants · Start Jan 30, 2020 · Primary completion Feb 2038
Device: Superion™ IDS device · For: Lumbar Spinal Stenosis
Sites: Carlsbad, California; Larkspur, California; Rancho Mirage, California · 23 sites in all
Boston Scientific CorporationPublic (BSX)
NCT04087811 · 1,674 participants · Start Nov 28, 2016 · Primary completion Mar 1, 2021
Device: Superion® Indirect Decompression System (IDS) · For: Lumbar Spinal Stenosis
Sites: Birmingham, Alabama; Phoenix, Arizona; Scottsdale, Arizona · 66 sites in all
VertiFlex, IncorporatedNot on our public-company list
NCT03048955 · 0 participants · Start Feb 8, 2017 · Primary completion Jul 31, 2022
Device: Superion® IDS · For: Spinal Stenosis, Lumbar Region With Neurogenic Claudication
Sites: Birmingham, Alabama; Carlsbad, California; Celebration, Florida · 5 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Superion Indirect Decompression", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NQO
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Superion Indirect Decompression"[tiab]. The summary above synthesizes these.
- The incidence of lumbar spine surgery following Minimally Invasive Lumbar Decompression and Superion Indirect Decompression System for treatment of lumbar spinal stenosis: a retrospective review.
Hagedorn JM, Yadav A, D'Souza RS, et al. · Pain Pract · 2022
- Interspinous process decompression is associated with a reduction in opioid analgesia in patients with lumbar spinal stenosis.
Nunley PD, Deer TR, Benyamin RM, et al. · J Pain Res · 2018
- Interspinous Process Decompression With The Superion® Spacer For Lumbar Spinal Stenosis: Real-World Experience From A Device Registry.
Tekmyster G, Sayed D, Cairns KD, et al. · Med Devices (Auckl) · 2019
Other devices of this type
Also filed under product code NQO.
- coflex® Interlaminar TechnologyCompanion Spine France · PMA 2026
- X-Stop Interspinous Spacer SystemMedtronic Sofamor Danek, Inc. · PMA 2012
- Superion Interspinous SpacerBoston Scientific Neuromodulation · PMA 2017
- coflex Interlaminar Stabilization DeviceCompanion Spine France · PMA 2021
- X Stop Interspinous Process Decompression SystemMedtronic Sofamor Danek, Inc. · PMA 2006
- DIAM Spinal Stabilization SystemCompanion Spine France Sas · PMA 2025
- Paradigm Spine Coflex Interlaminar Stabilization DeviceCompanion Spine France · PMA 2018
- X-Stop LtosMedtronic Sofamor Danek, Inc. · PMA 2014
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.